The most likely cause is erythropoietin deficiency (D). In patients with chronic kidney disease and renal failure, the kidneys produce less erythropoietin, leading to anemia. The anemia is normocytic and normochromic, consistent with anemia of chronic disease rather than a hereditary or autoimmune cause.
The most likely cause is erythropoietin deficiency (D). In patients with chronic kidney disease and renal failure, the kidneys produce less erythropoietin, leading to anemia. The anemia is normocytic and normochromic, consistent with anemia of chronic disease rather than a hereditary or autoimmune cause.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as PPT, PDF, TXT or read online from Scribd
The most likely cause is erythropoietin deficiency (D). In patients with chronic kidney disease and renal failure, the kidneys produce less erythropoietin, leading to anemia. The anemia is normocytic and normochromic, consistent with anemia of chronic disease rather than a hereditary or autoimmune cause.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as PPT, PDF, TXT or read online from Scribd
-Deep, rapid breathing (Kussmaul pattern) -Dry skin/mouth -Flushed face -Breath smells fruity (acetone) -N/V -Stomach pain DM Type I – Genes vs Environment Strongly influenced by environmental factors (possibly virus-related) as evidenced by studies of twins: only 50% chance of DM type 1 if identical twin has it, vs 75% chance w/ DM type 2
There is a genetic component: main gene is
IDDM1 (MHC Class II region of Chr. 6, @ 6p21) → beta cells display improper antigens to T cells
Increased genetic risk: HLA types DR3 & DR4
DM Type I - Dx
-Fasting glucose >= 126 mg/dL (100-125)
-Plasma glucose >= 200 mg/dL (140-199) two hr after 75g glucose load (GTT) -Glycated Hb (HbA1c) >= 6.5% (5.7-6.4)
If positive, repeat on a 2nd day to establish Dx
Approx 25% w/ new onset DM Type I develop
diabetic ketoacidosis before they are diagnosed DM Type I “Impaired Fasting Glucose”: fasting glucose between 100-125 mg/dL
“Impaired Glucose tolerance”: plasma glucose
after GTT between 140-199 mg/dL → major risk factor for: (1) progression to DM (2) cardiovascular disease
HbA1c between 5.7% and 6.4% is considered
“pre-diabetes” DM Type I - Treatment
Total daily insulin (TDI) = weight (in lb) / 4
(50:50 or 40:60 basal/bolus)
1 unit bolus = 12-15g carbs (can use 500/TDI)
= drops blood sugar by 30-100 mg/dL, avg 50mg/dL (can use 1800/TDI)
**Adjust dose for: exercise, travel, sickness, or
changes in caloric intake DM Type I – Types of Insulin DM Type I – Blood Sugar Levels
American Diabetes Association recommends
these blood sugar levels (in mg/dL): Before meal At bedtime Adults 70-130 <180 Teens 13- 90-130 90-150 19yo Kids 6-12yo 90-180 100-180 Kids <6yo 100-180 110-200 DM Type I - Complications: -Hypoglycemia: irritability, shaking/trembling, weakness, sweating, impaired coordination, drowsiness, confusion, headache, dizziness, diplopia, palpitations, seizures, unconsciousness
*Children w/ DM are more at risk of hypoglycemia
than adults & should maintain higher blood sugars
Other complications: cardiovascular disease,
diabetic neuropathy, diabetic retinopathy DM Type I – Preventative
-HbA1c every 3-6 mo
-Check skin & bones on feet & legs -Keep BP <= 130/80 mmHg -Annual BUN/creatinine & cholesterol/triglyceride tests -Visit opthalmologist at least once/year -Dentist appt every 6 mo -Regular exercise -Consistent meals DM Type I - Prevention -DiaPep277 (phase 3 trials): peptide fragment of HSP60, given subQ, induces Th1-Th2 shift (change from pro- to anti-inflammatory cytokines): clinical success in newly diagnosed DM Type I Pts (prolongs honeymoon period, when beta cells can be saved by insulin Tx)
-Bacillus Calmette-Guerin (BCG): inexpensive
generic drug for TB immunization, stimulates TNF-alpha production (helps immune system differentiate self from non-self), human trials began 2008 → permanent cure in 1/3 of test mice DM Type I – Prevention (cont'd)
-Diamyd vaccine: started phase 3 trials in USA in
2008, involves injection of GAD65 (autoantigen), delays destruction of beta cells for >= 30mo, recipients have higher lvls of regulatory cytokines (protective effect) Practice Question A 32-year-old woman with type 1 diabetes mellitus has had progressive renal failure over the past 2 years. She has not yet started dialysis. Examination shows no abnormalities. Her hemoglobin concentration is 9 g/dL, hematocrit is 28%, and mean corpuscular volume is 94 μm3. A blood smear shows normochromic, normocytic cells. Which of the following is the most likely cause?
How to Manage Diabetes and Cure?: Dr. Alan's Step By Step Guide for Diabetes Management Including General Tips, Diet Plan, Exercise Routine and Much More!